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4 - ORIGINAL ARTICLE
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ABSTRACT
PURPOSE: To evaluate the effect of Terazosin and Propranolol on the prevention of
necrosis induced by nicotine, in a random skin flap.
METHODS: This study utilized 32 adult male Wistar-EPM rats divided, at random,
into four groups of eight animals each. All the 32 animals received nicotine (2
mg/kg/day) subcutaneously, for one week before and one week after flap elevation. CG
(Control) group received distilled water (0.2 ml/day) by gavage and saline (0.5 ml)
intraperitoneally, for seven days in the postoperative period. TG (Terazosin) group
received terazosin hydrochloride (3 mg/day) by gavage and saline, intraperitoneally, for
seven days in the postoperative period. PG (Propranolol) group received propranolol
(1.5 mg/day) intraperitoneally and distilled water, by gavage, following the stablished
pattern. TPG (Terazosin + Propranolol) group received both drugs. On the seventh
postoperative day, the distal necrotic area of the flaps was determined via the paper
template method. Blood and skin samples were collected in order to allow
determination of Malondialdehyde (MDA) levels
RESULTS: The control group had a mean value of 39.5 % of necrosis; the Terazosin
group  25.1 %; the Propranolol group 34.5 % and the Terazosin + Propranolol group
26.2 % of necrosis. MDA levels in the serum and in the skin samples behave similarly,
with an exception regarding Propranolol group in this case.
CONCLUSION: Terazosin is effective in the prevention of necrosis in this animal
model and Propranolol is not effective in this case.
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RESUMO
OBJETIVO: O objetivo deste estudo experimental foi avaliar o efeito da Terazosina e do
Propranolol na prevenção da necrose induzida pela nicotina, em um retalho cutâneo
randômico.
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MÉTODOS: Este estudo utilizou 32 ratos machos adultos Wistar-EPM divididos, ao acaso,
em quatro grupos de oito animais. Todos os 32 animais receberam nicotina (2 mg/kg/dia),
por via subcutânea, por uma semana antes e uma semana após a elevação do retalho. O
grupo CG (Controle) recebeu água destilada (0,2 ml/dia), por gavagem e salina (0,5 ml),
por via intraperitoneal, por sete dias no período pós-operatório. O grupo TG (Terazosina)
recebeu terazosina (3 mg/dia), por gavagem, e salina, intraperitoneal, por sete dias no pós-
operatório. O grupo PG (Propranolol) recebeu propranolol (1,5 mg/dia), intraperitoneal e
água destilada, por gavagem, seguindo o padrão estabelecido. O grupo TPG (Terazosina +
Propranolol) recebeu ambas as drogas. No sétimo dia de pós-operatório, a área de necrose
distal dos retalhos foi determinada pelo método do gabarito de papel. Amostras de sangue e
de pele foram coletadas de forma a permitir a determinação dos níveis de malondialdeído
(MDA).
RESULTADOS: O grupo controle apresentou um valor médio de necrose de 39,5 %; o
grupo Terazosina 25,1 %; o grupo Propranolol 34,5 % e o grupo Terazosina + Propranolol
26,2 % de necrose. Os níveis de MDA no soro e nas amostras de pele comportaram-se de
maneira similar, com uma exceção no caso do grupo Propranolol neste caso.
CONCLUSÃO: A Terazosina foi eficaz na prevenção da necrose neste modelo animal e o
Propranolol não foi eficaz neste caso.
Descritores: Retalhos cirúrgicos. Nicotina. Peroxidação lipídica. Terazosina. Propranolol.
Ratos.
Introduction
Nicotine induced skin flap necrosis is a matter of great concern to the Plastic
Surgeon1, 2. Even understanding that elective cosmetic surgery may be postponed until
the patient quits smoking, there is an important percentage of this specific population
that simply cannot function without cigarette smoking. In order to reduce the risk of
postoperative necrosis in smokers, many experimental studies have been carried out3, 4, 5,
6, 7, particularly in the field of antioxidants3, 8. Antioxidants are substances that prevent
or reduce the deleterious effects of the oxidative stress that occurs after elevation of
surgical flaps, at the moment of reperfusion. An effective block of the oxidative stress
prevents or reduces necrosis in the flap. Malondialdehyde (MDA) is a product of lipid
peroxidation (oxidative stress in cellular membranes) and is used as a monitor of the
oxidative phenomenon.
Nicotine is associated with flap necrosis, mainly due to vasoconstriction3, 4, 5, 6, 7.
The specific mechanism involves stimulation of norepinephrine release by nicotinic
cholinergic receptors, with stimulation of a1-adrenergic receptors of smooth muscle
cells. Terazosin hydrochloride, an a1-specific neuroreceptor antagonist, reduced
nicotine induced skin flap necrosis in the rat7, but a possible antioxidant action was not
analyzed. Similarly, propranolol, a beta receptor blocker, proved effective in the acute
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myocardial infarction9 but, again, no antioxidant role was studied. In fact, theoretically,
the association of both drugs may, indeed, be favorable in preventing flap necrosis.
Methods
Thirty-two adult male Wistar-EPM rats were divided, at random, into four
groups of eight animals each. All the 32 animals received nicotine (2 mg/kg/day)
subcutaneously, for one week before and one week after flap elevation. CG (Control)
group received distilled water (0.2 ml/day) by gavage and saline (0.5 ml)
intraperitoneally, for seven days in the postoperative period. TG (Terazosin) group,
received terazosin (3 mg/day) by gavage and saline, in a similar way and period of time.
PG (Propranolol) group, received propranolol (1.5 mg/day) intraperitoneally and
distilled water following the stablished pattern. TPG (Terazosin + Propranolol) group
received both drugs.
After anesthesia with pentobarbital (40 mg/kg) intraperitoneally, the back of the
rat was shaved and a random cranial based, dorsal skin flap was elevated, measuring 10
x 4 cm10. A plastic barrier was placed between the flap and its bed11. Simple 4-0 naylon
stitches were then used to close the wound. On the seventh postoperative day, the distal
necrotic area of the flap was determined via the paper template method12. Blood and
skin samples were collected in order to allow determination of MDA levels13. One
sample was obtained 5 cm distal to the flap basis, in the middle of the flap and in the
midline (flap sample) and the other, 1 cm lateral to the flap basis, on the right side, from
a normal skin area (normal skin sample). The skin samples measured 1 cm2.
The methods herein presented were approved by UNIFESP-EPM’s Ethical
Commitee.
Results
The necrotic area in CG (control) ranged between 23.9 % and 51.3 % (average
39.5 %); in group TG (Terazosin) ranged between 15.5 % and 49.7 % (average 25.2 %);
in PG (Propranolol) ranged between 16.9 %  and 52 % (average 34.5 %) and in group
TPG (Terazosin + Propranolol) ranged between 20.7 % and 34 % (average 26.2 %).
Statistical analysis showed difference between groups CG and TG; CG and TPG
(Mann-Whitney’s Test; p< 0.02) (Table 1, Figure 1).
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TABLE 1 - Percentage of necrotic area on the seventh postoperative day.
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FIGURE 1 - Average percentage of necrotic area on the seventh postoperative day.
MDA serum concentrations in CG (control) ranged between 1634 ng/ml and
4716 ng/ml (average 3395 ng/ml); in TG (Terazosin) ranged between 2472 ng/ml and
7910 ng/ml (average 3774 ng/ml); in PG (Propranolol) ranged between 1702 ng/ml and
CG
(control)
TG
(terazosin)
PG
(propranolol)
TPG
(tera/prop)
Animal 1 23.9 20.6 48.1 29.1
             2 43.3 18.7 25.3 34
             3 34.3 25.4 52 25.3
             4 51.3 21.8 16.9 23
             5 50 16.7 40 28.4
             6 49.9 15.5 Died 27.4
             7 30.8 32.8 38.4 22
             8 32.8 49.7 20.7 20.7
Average (%) 39.5 25.2 34.5 26.2
SD 10.4 11.3 13.7 4.4
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3826 ng/ml (average 2504 ng/ml) and in TPG (Terazosin + Propranolol) ranged
between 2628 ng/ml and 3782 ng/ml (average 3202 ng/ml). Statistical analysis showed
no difference between the groups (Variance Analysis; p = 0.19) (Table 2, Figure 2).
TABLE 2 - Average concentration of Malondialdehyde (ng/ml) in the serum collected
on the seventh postoperative day.
CG
  (control)
TG
 (terazosin)
PG
(propranolol)
TPG
 (tera/prop)
Average(ng/ml) 3395 3774 2504 3202
SD 1001 1758 760 460
FIGURE 2 - Average concentration of malondialdehyde (ng/ml) in the serum collected on the seventh
postoperative day.
MDA levels in the flap samples ranged between 21 ng/ml and 331 ng/ml
(average 150 ng/ml) in CG (control); between 0 ng/ml and 694 ng/ml (average 130
ng/ml) in TG (Terazosin); between 64 ng/nl and 4677 ng/ml (average 2387 ng/ml) in
PG (Propranolol) and between 464 ng/ml and 2845 ng/ml (average 1264 ng/ml) in TPG
(Terazosin + Propranolol).
MDA levels in the normal skin samples ranged between 0 ng/ml and 331 ng/ml
(average 106 ng/ml) in CG (control); between 0 ng/ml and 69 ng/ml (average 65 ng/ml)
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in TG (Terazosin); between 111 ng/ml and 1718 ng/ml (average 717 ng/ml) in PG
(Propranolol) and between 277 ng/ml and 3904 ng/ml (average 1378 ng/ml) in TPG
(Terazosin + Propranolol) (Table 3, Figure 3).
TABLE 3 - Average concentration of malondialdehyde (ng/ml) measured from the flap
and normal samples of skin on the seventh postoperative day.
FIGURE 3 - Average concentration of malondialdehyde (ng/ml) measured from the flap and normal skin
on the seventh postoperative day.
Statistical analysis of the MDA levels in the skin samples (flap x normal skin),
inside the groups, showed difference in group PG (Propranolol), in which these levels
were higher in the flap samples (Linear Paried Analysis; p = 0.12).
Comparisons between the groups showed, for the flap samples, that MDA levels
in groups PG (Propranolol) and TPG (Terazosin + Propranolol) were higher than in
CG
  (control)
TG
 (terazosin)
PG
(propranolol)
TPG
 (tera/prop)
flap normal Flap normal flap normal flap Normal
Average 150 106 130 65 2387 717 1264 1378
SD 143 110 231 89 1820 544 798 1482
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groups CG (control) and TG (Terazosin) (Paried Significance; p values varied between
< 0.001 and  0.003).
Comparisons between the groups showed, for the normal skin samples, that
MDA levels in groups PG (Propranolol) and TPG (Terazosin + Propranolol) were also
higher than in groups CG (control) and TG (Terazosin) (Paried Significance; p values
varied between < 0.001 and 0.006).
Discussion
Ischemia and necrosis are well known complications in Plastic Surgery. Random
skin flaps are particularly risky and any measure that reduces this risk is welcome3, 4, 5, 6,
7. Recent knowledge of the undesirable effects of free radicals in skin flaps was
followed by a myriad of clinical and laboratory studies and the importance of the
antioxidant substances was stressed3, 8.
Malondialdehyde (MDA), a product of lipid peroxidation, is useful in
experimental studies that focus on antioxidant drugs, since its values reflect the
oxidative stress to which the animal is exposed. Classically, MDA levels rise in the flap
itself and the normal skin values are used as control. Serum levels were measured as a
parameter of nicotine presence in the circulation, since they are elevated in rats exposed
to nicotine effect3.
The present rat model provoked both ischemia and necrosis in the flaps with
local liberation of lipid peroxidation products. Also, malondialdehyde (MDA) levels in
the serum were similar in all groups and, as expected, high. These elevated values are
similar to those found in a previous study3, and represent a direct result of the presence
of nicotine in the circulation. These MDA levels do not reflect the events that occurred
in the flap.
As expected, percentages of distal necrosis in the control (CG) rats flaps were
high (average 39.5 %), indicating the deleterious effect of nicotine, as evidenced
before3, 4, 5, 6, 7. It is important to notice that, according to Forrest et al5,6, a four weeks
preoperative period of nicotine injection was necessary to increase distal flap necrosis,
what proved not true in this experiment, which used nicotine preoperatively for one
week only and obtained similar results.
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Terazosin, an a1-specific neuroreceptor antagonist, reduced nicotine induced
skin flap necrosis in the present experimental model, both alone (average 25.1 % of
necrosis) and associated with Propranolol (average 26.2 % of necrosis), when compared
to the control (average 39.5 % of necrosis). This result for Terazosin is in accordance to
the work of Karlen and Maisel7, which used the same doses of nicotine and Terazosin in
a similar random-pattern flap, in the rat.
Regarding the possible role of Terazosin as an antioxidant substance, the data
obtained showed that malondialdehyde (MDA) levels in both serum and skin samples
were similar to those found in the control rats. Therefore, it seems that this drug does
not act as an antioxidant, in spite of its necrosis reduction capability, probably explained
by its vascular action.
Propranolol, a beta receptor blocker, did not reduce nicotine induced skin flap
necrosis in the herein presented experimental model (average 34.5 % of necrosis), when
compared to the control (average 39.5 % of necrosis). Indeed, the finding that the
association with Terazosin reduced the percentage of necrosis (average 26.2 %
necrosis), strongly suggests that this was the really efficient substance.
As regards the possible role of Propranolol as an antioxidant drug, the findings
showed that malondialdehyde (MDA) levels in the serum were similar to those found in
control and Terazosin groups, suggesting no systemic antioxidant action. Nevertheless,
in the skin samples, MDA values were much higher than those found in the control and
Terazosin groups, suggesting even a local oxidant effect (Figure 3).
Terazosin, the effective drug in this study, is currently used in the reduction of
prostatic urethral smooth muscle contraction, with consequent improvement in urinary
flow, in normotensive elderly men with benign prostatic hypertrophy14. This drug is
well tolerated in this population, with minimal side effects7, what justifies its clinical
use to improve skin flap survival in smokers.
The herein presented data stresses the importance of Terazosin as a flap necrosis
reduction drug, at least in this particular experimental model, and elicits the adequacy of
the study of this drug in experiments involving different kinds of flaps.
Conclusion
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Terazosin is effective in the prevention of necrosis in this animal model and
Propranolol is not effective in this case.
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